Introduction

Company name: Pfizer Limited

Address: Ramsgate Road

Sandwich

Kent CT13 9NJ

Telephone: 0845 300 8034 (Out of hours: 01304 616161)

Fax: 01737 332521

Email: UKVetLine@pfizer.com

Website: www.only4vets.co.uk

Presentation

White scored tablets containing 100 mg or 500mg lincomycin (as lincomycin hydrochloride).

Uses

Antibiotic. For the treatment of infections such as infected dermatitis, abscesses, infected wounds, tonsillitis, laryngitis and metritis caused by lincomycin susceptible Gram-positive organisms, particularly streptococci and staphylococci.

Dosage and administration

Oral.

Dogs and cats

22 mg/kg body weight every 12 hours or 15 mg/kg bodyweight every 8 hours.

Contra-indications, warnings, etc

For animal treatment only. Keep out of the reach of children. Clinical antagonism may occur between lincomycin and erythromycin due to competitive binding at the ribosomal site of action. This antibiotic is not effective against Gram-negative aerobic organisms, Enterococcus faecalis or yeasts. Not recommended in species other than the cat and the dog. Loose stools have been observed occasionally in animals on high oral dosage but will usually self-correct without discontinuing medication. If the problem worsens, discontinue treatment.

Operator warnings

In case of accidental ingestion seek medical advice immediately and show the label to the doctor. People with known hypersensitivity to lincomycin should avoid contact with the product. Wash hands with soap and water after use.

Pharmaceutical precautions

Do not store above 25°C. Store in a dry place. Store in tightly closed original container.

Any unused product or waste material should be disposed of in accordance with national requirements.

Legal category

POM-V

Packaging Quantities

Supplied in plastic tubs of 100 x 100 mg tablets or 50 x 500 mg tablets.

Further information

Lincomycin is a lincosamide antibiotic with excellent activity against Gram-positive bacteria and certain Gram-negative anaerobic bacteria and mycoplasma. It is well absorbed and distributed throughout the body, particularly in areas of poor vascular supply. At the recommended dosage, supra-MIC levels are attained for the full interdose interval.

Marketing authorisation numbers

100 mg	Vm 00057/4252
500 mg	Vm 00057/4253